PainReform Ltd. (PRFX) Social Stream
PAINREFORM LTD (PRFX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PRFX.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued April 8, 2022
The Trend in the Analyst Price Target
Over the past 18 months, PRFX's average price target has gone down $7.
500 - Internal server error
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
PRFX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PRFX as an investment opportunity.
- In terms of how PAINREFORM LTD fares relative to all US stocks, note that its number of analysts covering the stock is higher than practically none of that group.
- To contextualize these metrics, consider that out of all US stocks, PAINREFORM LTD's variance in analysts' estimates is lower than almost 100% of them.
- In the context of Healthcare stocks, PAINREFORM LTD's average analyst price target is greater than 12.66% of them.
- In terms of how PAINREFORM LTD fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is higher than 166% of that group.
In the Pharmaceutical Products industry, INM, PTPI, and GRI are the three stocks most similar to PAINREFORM LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is PRFX a Buy, Hold or Sell? See the POWR Ratings now!